.png){kind=icon}
返回
S
Santosh Kumar Guru
national institute of pharmaceutical education and research
37H指数
166论文数
3.7K被引数
收录论文 83
发表时间
.png){kind=icon}
Discovery of 2-(4-Ureido-piperidin-1-yl)-4-morpholinothieno [3; 2-D] Pyrimidines as Orally Bioavailable Phosphoinositide-3-Kinase Inhibitors with In Vitro and In Vivo Antitumor Efficacy in Triple-Negative Breast Cancer作为口服可利用的磷脂酰肌醇-3-激酶抑制剂，2-(4-脲基-哌啶-1-基)-4-吗啉基噻吩并[3;2-D]嘧啶在体外和体内对三阴性乳腺癌均显示出抗肿瘤疗效。.png)
PREAI
.png){kind=icon}
分享.png){kind=icon}
收藏Olaparib-Cediranib Hybrid as Dual PARP-VEGFR3 Inhibitor Elicits Antitumor Efficacy: Rational Design, Synthesis, Biological Evaluation and Construction of a Charge Convertible pH Responsive Nanoformulation奥拉帕利-塞地拉尼杂合体作为双PARP-VEGFR3抑制剂显示出抗肿瘤活性：合理设计、合成、生物评价及电荷可转换pH响应纳米制剂的构建.png)
Bioorganic Chemistry
Bioorganic ChemistryIF4.7
PREAI
分享收藏